Valuation: Infopia Co.,Ltd

Market Cap 87.95B 0 64.9M 56.72M 53.21M 48.72M 91.2M 6.2B 91.11M 638M 246M 3.17B 244M 238M 10.24B P/E 2024
-13.6x
P/E 2025 52.5x
Enterprise Value 90.43B 0 66.74M 58.33M 54.71M 50.1M 93.78M 6.38B 93.69M 656M 253M 3.26B 251M 245M 10.53B EV / Sales 2024
1.82x
EV / Sales 2025 1.29x
Free-Float
37.73%
Yield 2024
4.39%
Yield 2025 -
07/09/25 Sewon Co.,Ltd and Polaris AI Corp. completed the acquisition of 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae. CI
20/07/25 Sewon Co.,Ltd and Polaris AI Corp. agreed to acquire 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae for KRW 50 billion. CI
15/12/24 Osang Healthcare Co.,Ltd announces Annual dividend, payable on April 10, 2025 CI
23/09/24 Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024. CI
23/09/24 Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024. CI
16/09/24 Osang Healthcare Co.,Ltd's Equity Buyback announced on June 17, 2024, has expired with 315,680 shares, representing 2.27% for KRW 4,993.67 million. CI
17/06/24 Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares. CI
16/06/24 Osang Healthcare Co.,Ltd authorizes a Buyback Plan. CI
21/05/24 Allez Health, Inc. announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd CI
23/04/24 Zense-Life Inc announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd and other investors CI
27/03/24 Kryptos Biotechnologies, Inc. announced that it has received $10 million in funding from Osang Healthcare Co.,Ltd CI
17/03/24 Kryptos Biotechnologies, Inc. announced that it expects to receive $27.095308 million in funding from Osang Healthcare Co.,Ltd CI
Manager TitleAgeSince
Chief Executive Officer 65 -
Chief Executive Officer 58 -
Chief Operating Officer 52 -
Director TitleAgeSince
Director/Board Member 58 -
Director/Board Member 57 10/08/2020
Chairman 67 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%+5.55%+199.51%+578.51% 23.33B
+2.02%+15.10%+518.87%+92.56% 10.31B
+1.31%+2.38%-35.63%-18.76% 9.76B
+2.68%+20.81%-3.41% - 8.66B
-0.28%-0.32%+98.37%+65.92% 6.55B
+0.86%+1.92%-27.31%-20.73% 5.76B
-2.31%+3.09%-3.15%-12.72% 4.43B
+0.89%+8.70%+66.62%+72.10% 4B
+7.53%+10.21%-13.10%-24.70% 2.77B
Average +1.62%+6.53%+88.97%+91.52% 8.4B
Weighted average by Cap. +1.57%+6.17%+136.69%+220.41%

Financials

2024 2025
Net sales 80.49B 0 59.4M 51.91M 48.7M 44.59M 83.47M 5.68B 83.39M 584M 226M 2.9B 223M 218M 9.37B 129B 0 94.93M 82.97M 77.82M 71.26M 133M 9.07B 133M 933M 360M 4.63B 356M 349M 14.98B
Net income -11.36B -0 -8.39M -7.33M -6.88M -6.3M -11.78M -802M -11.77M -82.47M -31.84M -409M -31.49M -30.8M -1.32B 3.11B 0 2.29M 2.01M 1.88M 1.72M 3.22M 219M 3.22M 22.56M 8.71M 112M 8.61M 8.43M 362M
Net Debt -9.47B -0 -6.99M -6.11M -5.73M -5.25M -9.82M -668M -9.81M -68.73M -26.54M -341M -26.25M -25.67M -1.1B 2.49B 0 1.84M 1.6M 1.51M 1.38M 2.58M 175M 2.58M 18.06M 6.97M 89.61M 6.89M 6.74M 290M
Logo Infopia Co.,Ltd
Osang HealthCare Co Ltd is a Korea-based company primarily engaged in research and development of in vitro diagnostic medical devices. The Company operates through three segments. The Biochemical Diagnostic segment mainly develops products such as personal blood sugar measurement devices, glycated hemoglobin measurement devices, cholesterol measurement devices, liver disease measurement devices, and U-healthcare devices. The Immunodiagnostic segment is mainly engaged in the development of immunodiagnostic devices and measurement sensors. The Molecular Diagnostic segment mainly engages in the development of molecular diagnostic devices and reagents.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!